APA (7th ed.) Citation

Z, F., H, K., J, R., F, O., T, N., A, M., . . . I, M. (2023). Azilsartan inhibits inflammation-triggered bone resorption and osteoclastogenesis in vivo via suppression of TNF-α expression in macrophages. Frontiers in endocrinology, 14, 1207502. https://doi.org/10.3389/fendo.2023.1207502

Chicago Style (17th ed.) Citation

Z, Fan, et al. "Azilsartan Inhibits Inflammation-triggered Bone Resorption and Osteoclastogenesis in Vivo via Suppression of TNF-α Expression in Macrophages." Frontiers in Endocrinology 14 (2023): 1207502. https://doi.org/10.3389/fendo.2023.1207502.

MLA (9th ed.) Citation

Z, Fan, et al. "Azilsartan Inhibits Inflammation-triggered Bone Resorption and Osteoclastogenesis in Vivo via Suppression of TNF-α Expression in Macrophages." Frontiers in Endocrinology, vol. 14, 2023, p. 1207502, https://doi.org/10.3389/fendo.2023.1207502.